Matches in SemOpenAlex for { <https://semopenalex.org/work/W4360839248> ?p ?o ?g. }
- W4360839248 endingPage "142597" @default.
- W4360839248 startingPage "142597" @default.
- W4360839248 abstract "Conventional chemotherapy lacks the ability to specifically target cancer cells, thus although it eliminates tumor tissues to some extent, it also damages normal tissues and organs. Meanwhile, cancer stem cells (CSCs)-induced tumor regrowth and drug resistance limits the application of some chemotherapy drugs. In this study, the CD71/CD44 dual-aptamer-gemcitabine (CD71-CD44-GEMs) conjugate was designed to treat bladder cancer through the co-targeting by CD71 of bladder cancer cells and by CD44 of bladder CSCs. A series of studies were used to evaluate the binding specificity and the in vitro and in vivo anti-cancer effects. We observed that CD71-CD44-GEMs selectively bound to and exerted a high inhibitory effect on bladder cancer in vitro and in vivo. Besides, CD71-CD44-GEMs can inhibit the formation of the tumorsphere and demonstrated a higher binding affinity and inhibitory efficacy than CD71-GEMs or CD44-GEMs (GEM delivered by a single target aptamer) in bladder cancer. Hence, CD71-CD44-GEMs represents a promising approach to treating bladder cancer for its high efficacy in drug delivery and ability to eliminate both bladder cancer cells and CSCs." @default.
- W4360839248 created "2023-03-25" @default.
- W4360839248 creator A5001026491 @default.
- W4360839248 creator A5013975435 @default.
- W4360839248 creator A5017945055 @default.
- W4360839248 creator A5019056615 @default.
- W4360839248 creator A5028490219 @default.
- W4360839248 creator A5033216492 @default.
- W4360839248 creator A5034435664 @default.
- W4360839248 creator A5040009629 @default.
- W4360839248 creator A5041527056 @default.
- W4360839248 creator A5042183753 @default.
- W4360839248 creator A5061795808 @default.
- W4360839248 creator A5064672616 @default.
- W4360839248 creator A5070502927 @default.
- W4360839248 creator A5076573585 @default.
- W4360839248 creator A5080243119 @default.
- W4360839248 creator A5080932283 @default.
- W4360839248 date "2023-05-01" @default.
- W4360839248 modified "2023-09-26" @default.
- W4360839248 title "CD71/CD44 dual-aptamer-gemcitabine conjugate for tumor co-targeting treatment of bladder cancer" @default.
- W4360839248 cites W1535485604 @default.
- W4360839248 cites W1992473950 @default.
- W4360839248 cites W1994599132 @default.
- W4360839248 cites W1999362080 @default.
- W4360839248 cites W2018569307 @default.
- W4360839248 cites W2020131167 @default.
- W4360839248 cites W2029608148 @default.
- W4360839248 cites W2045246542 @default.
- W4360839248 cites W2084251083 @default.
- W4360839248 cites W2111091957 @default.
- W4360839248 cites W2135889186 @default.
- W4360839248 cites W2143995836 @default.
- W4360839248 cites W2150133812 @default.
- W4360839248 cites W2161983416 @default.
- W4360839248 cites W2187929102 @default.
- W4360839248 cites W2510690438 @default.
- W4360839248 cites W2550154271 @default.
- W4360839248 cites W2550294854 @default.
- W4360839248 cites W2573963236 @default.
- W4360839248 cites W2590838410 @default.
- W4360839248 cites W2603508083 @default.
- W4360839248 cites W2604611511 @default.
- W4360839248 cites W2754890747 @default.
- W4360839248 cites W2756575490 @default.
- W4360839248 cites W2765418773 @default.
- W4360839248 cites W2770476885 @default.
- W4360839248 cites W2885214828 @default.
- W4360839248 cites W2886506156 @default.
- W4360839248 cites W2892586379 @default.
- W4360839248 cites W2903510641 @default.
- W4360839248 cites W2926145338 @default.
- W4360839248 cites W2964275549 @default.
- W4360839248 cites W2970691274 @default.
- W4360839248 cites W2971174501 @default.
- W4360839248 cites W2979399812 @default.
- W4360839248 cites W3029881948 @default.
- W4360839248 cites W3036987403 @default.
- W4360839248 cites W3039333879 @default.
- W4360839248 cites W3092254857 @default.
- W4360839248 cites W3113785507 @default.
- W4360839248 cites W3137962164 @default.
- W4360839248 cites W3172039897 @default.
- W4360839248 cites W3202738505 @default.
- W4360839248 cites W3212858120 @default.
- W4360839248 cites W4210546033 @default.
- W4360839248 cites W4221102109 @default.
- W4360839248 doi "https://doi.org/10.1016/j.cej.2023.142597" @default.
- W4360839248 hasPublicationYear "2023" @default.
- W4360839248 type Work @default.
- W4360839248 citedByCount "0" @default.
- W4360839248 crossrefType "journal-article" @default.
- W4360839248 hasAuthorship W4360839248A5001026491 @default.
- W4360839248 hasAuthorship W4360839248A5013975435 @default.
- W4360839248 hasAuthorship W4360839248A5017945055 @default.
- W4360839248 hasAuthorship W4360839248A5019056615 @default.
- W4360839248 hasAuthorship W4360839248A5028490219 @default.
- W4360839248 hasAuthorship W4360839248A5033216492 @default.
- W4360839248 hasAuthorship W4360839248A5034435664 @default.
- W4360839248 hasAuthorship W4360839248A5040009629 @default.
- W4360839248 hasAuthorship W4360839248A5041527056 @default.
- W4360839248 hasAuthorship W4360839248A5042183753 @default.
- W4360839248 hasAuthorship W4360839248A5061795808 @default.
- W4360839248 hasAuthorship W4360839248A5064672616 @default.
- W4360839248 hasAuthorship W4360839248A5070502927 @default.
- W4360839248 hasAuthorship W4360839248A5076573585 @default.
- W4360839248 hasAuthorship W4360839248A5080243119 @default.
- W4360839248 hasAuthorship W4360839248A5080932283 @default.
- W4360839248 hasConcept C121608353 @default.
- W4360839248 hasConcept C126322002 @default.
- W4360839248 hasConcept C150903083 @default.
- W4360839248 hasConcept C185592680 @default.
- W4360839248 hasConcept C202751555 @default.
- W4360839248 hasConcept C207001950 @default.
- W4360839248 hasConcept C2780258809 @default.
- W4360839248 hasConcept C2780352672 @default.
- W4360839248 hasConcept C2780932548 @default.
- W4360839248 hasConcept C502942594 @default.